Hamed T. Ghomi is a scientist with over a decade of experience in computational molecular design, with a focus on peptide and protein engineering. He has led projects across industry and academia, including roles at companies such as Illumina, where he contributed to innovations in enzyme design and drug discovery. He is the founder and CEO of Complexicom Ltd, a company specializing in computational protein engineering. In parallel, Hamed holds the position of Sowerby Lecturer at King’s College London, where he teaches and publishes on the theoretical foundations of scientific practice. His academic research explores evidence, modeling, and complexity in the life sciences and medicine. His work bridges computational and conceptual analysis to drive advances in biomedical research.